Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01602289 | A Study of LY2875358 in Japanese Participants With Advanced Cancer | completed | Phase 1 | 17 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 8, 2015 | clinicaltrials |
| NCT02199548 | The Good Patient Study | completed | — | 43 | St. Jude Children's Research HospitalOTHER | 1 | Jun 4, 2015 | clinicaltrials |
| NCT00770263 |
| Erlotinib and Temsirolimus for Solid Tumors |
| completed |
| Phase 1 |
| 46 |
| Washington University School of MedicineOTHER |
| 1 |
| Jun 3, 2015 |
| clinicaltrials |
| NCT00388427 | Safety Study Of Cetuximab Plus Dasatinib (BMS-354825) in Treating Advanced Solid Malignancies | completed | Phase 1 | 31 | University of PittsburghOTHER | 1 | May 28, 2015 | clinicaltrials |
| NCT00423865 | Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 25, 2015 | clinicaltrials |
| NCT01281150 | Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 22 | National Cancer Institute (NCI)NIH | 1 | May 25, 2015 | clinicaltrials |
| NCT00535119 | Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer | completed | Phase 1 | 107 | National Cancer Institute (NCI)NIH | 1 | May 22, 2015 | clinicaltrials |
| NCT00521144 | Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 22 | National Cancer Institute (NCI)NIH | 1 | May 5, 2015 | clinicaltrials |
| NCT00070252 | Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer | completed | Phase 1 / Phase 2 | 53 | National Cancer Institute (NCI)NIH | 1 | May 4, 2015 | clinicaltrials |
| NCT00245076 | Smokefree.Gov Website in Helping United States Federal Employees Quit Smoking | completed | N/A | — | National Cancer Institute (NCI)NIH | 1 | May 1, 2015 | clinicaltrials |
| NCT01343498 | Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors | completed | Phase 1 | 33 | SCRI Development Innovations, LLCOTHER | 1 | May 1, 2015 | clinicaltrials |
| NCT00018967 | Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate | completed | N/A | 10 | National Cancer Institute (NCI)NIH | 4 | Apr 30, 2015 | clinicaltrials |
| NCT00020488 | Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00030095 | 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00042861 | UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00045500 | UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00072111 | Anakinra in Treating Patients With Metastatic Cancer Expressing the Interleukin-1 Gene | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00003993 | Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma | completed | Phase 1 | 24 | National Institute on Aging (NIA)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00019344 | Flavopiridol in Treating Patients With Refractory Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00019357 | Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00019656 | Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00020150 | Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00040729 | Genetic Study of Patients Previously Treated With Flavopiridol on Clinical Trial NCI-97-C-0171C | completed | — | — | National Cancer Institute (NCI)NIH | 1 | Apr 28, 2015 | clinicaltrials |
| NCT00343629 | Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers | completed | N/A | 28 | Mayo ClinicOTHER | 1 | Apr 28, 2015 | clinicaltrials |
| NCT01463982 | Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies | completed | Phase 1 | 21 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 1 | Apr 23, 2015 | clinicaltrials |
| NCT00217373 | Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA) | completed | Phase 1 | 33 | National Cancer Institute (NCI)NIH | 1 | Apr 20, 2015 | clinicaltrials |
| NCT00871663 | Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6) | completed | Phase 1 | 123 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Apr 20, 2015 | clinicaltrials |
| NCT00021216 | Bortezomib in Treating Children With Advanced Solid Tumors | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00255658 | Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT01603979 | A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors | completed | Phase 1 | 24 | AVEO Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 8, 2015 | clinicaltrials |
| NCT00049400 | S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction | completed | Phase 1 | 78 | SWOG Cancer Research NetworkNETWORK | 1 | Apr 3, 2015 | clinicaltrials |
| NCT00951184 | Depression Screening in Patients Undergoing Radiation Therapy For Cancer | completed | — | 463 | Radiation Therapy Oncology GroupNETWORK | 1 | Mar 18, 2015 | clinicaltrials |
| NCT01688960 | Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid Malignancies | completed | Phase 1 | 48 | Regeneron PharmaceuticalsINDUSTRY | 2 | Mar 17, 2015 | clinicaltrials |
| NCT00888043 | Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors(CNTO95/Avastin) | completed | Phase 1 | 13 | Herbert Hurwitz, MDOTHER | 1 | Mar 11, 2015 | clinicaltrials |
| NCT01234012 | Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1 | completed | Phase 1 | 23 | ImmunoFrontier, Inc.INDUSTRY | 1 | Mar 10, 2015 | clinicaltrials |
| NCT00352443 | S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma | completed | Phase 1 | 66 | SWOG Cancer Research NetworkNETWORK | 1 | Mar 6, 2015 | clinicaltrials |
| NCT00704054 | A Multi-Center Phase I Study of Intravenous Deforolimus (AP23573, MK-8669) Administered QDX5 Every Other Week in Pediatric Patients With Advanced Solid Tumors (8669-028)(COMPLETED) | completed | Phase 1 | 15 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Feb 13, 2015 | clinicaltrials |
| NCT00781846 | Trial of Deforolimus in Combination With Bevacizumab for Patients With Advanced Cancers (8669-010)(COMPLETED) | completed | Phase 1 | 17 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Feb 13, 2015 | clinicaltrials |
| NCT01853345 | iCAT for Recurrent/Refractory/HR Solid Tumors | completed | — | 101 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 10, 2015 | clinicaltrials |
| NCT01844869 | An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate | completed | Phase 1 | 6 | Teva Branded Pharmaceutical Products R&D, Inc.INDUSTRY | 1 | Jan 30, 2015 | clinicaltrials |
| NCT00879684 | Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors | completed | Phase 1 | 34 | PfizerINDUSTRY | 1 | Jan 26, 2015 | clinicaltrials |
| NCT00635596 | Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer(MT110-101) | completed | Phase 1 | 65 | Amgen Research (Munich) GmbHINDUSTRY | 1 | Jan 13, 2015 | clinicaltrials |
| NCT00487331 | Acupuncture for Treatment of Uncontrolled Pain: A Feasibility Study | completed | N/A | 52 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 9, 2015 | clinicaltrials |
| NCT00665990 | Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia | completed | Phase 1 | 49 | St. Jude Children's Research HospitalOTHER | 1 | Jan 9, 2015 | clinicaltrials |
| NCT00968643 | Spinal Cord Compression. ICORG 05-03, V6 | completed | Phase 3 | 126 | Cancer Trials IrelandNETWORK | 1 | Dec 31, 2014 | clinicaltrials |
| NCT01131234 | Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Dec 23, 2014 | clinicaltrials |
| NCT01218620 | Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 17 | National Cancer Institute (NCI)NIH | 1 | Dec 23, 2014 | clinicaltrials |
| NCT00813384 | A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors | completed | Phase 1 | 54 | AmgenINDUSTRY | 1 | Dec 16, 2014 | clinicaltrials |
| NCT00217477 | Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer | completed | Phase 1 | 34 | Roswell Park Cancer InstituteOTHER | 1 | Dec 9, 2014 | clinicaltrials |
| NCT00964275 | Standard Diagnostic Procedures With or Without Fludeoxyglucose F 18 Positron Emission Tomography in Finding Cancer in Patients With a Blood Clot in a Vein(MVTEP) | completed | N/A | 400 | University Hospital, BrestOTHER | 1 | Dec 8, 2014 | clinicaltrials |
Data updated 24 days agoSource updated Jun 8, 2015source: clinicaltrials